Tuesday, June 9, 2026

Latest

GameStop: Consensus Estimates Point To Negative EBITDA For Q3

GameStop (NYSE: GME) will be reporting its third quarter financial results on December 8th after the market closes. Analysts have a consensus $88 12-month price target on the company, via a total of 3 analysts, with 1 analyst having a hold rating, another analyst having a sell rating, and the last analyst having a strong sell rating. The street high comes in at a $190 price target, and the lowest target sits at $24.

Only 4 analysts have revenue estimates for the third quarter. The mean revenue estimate between all 4 analysts is $1.19 billion; this number has been up and down but is flat now since early June. The highest revenue estimate is $1.30 billion, while the lowest is $1.01 billion.

Onto EBITDA estimates, there are currently only 2 analysts who have third quarter EBITDA estimates. The mean is currently -$15 million, with this number being slightly revised lower since early June. The street high estimate currently sits at $12 million in EBITDA and the lowest is -$42 million.

Analysts estimate that quarterly earnings per share will come in at -$0.52, with this number being flat since early June. Street high is -$0.04 and the lowest estimate is -$0.87 per share for the quarter.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

The Gold Trade Is Shifting From Margins to Growth | Geordie Mark – Blue Jay Gold

CopAur Minerals – This PEA Has A Mine Life of What?!

Ontario’s Fast Track to Silver Production Is Starting to Matter | Frank Basa – Nord Precious Metals

Recommended

Antimony Resources Trenching at Bald Hill Averages 19.5% Antimony, Peaks at 44.2%

Amid CBS Shuffle, Is Joe Rogan Replacing Anderson Cooper On 60 Minutes?

Related News

Haywood Lowers Tilray Price Target To $7.25

On January 10th, Tilray Inc (TSX: TLRY) reported their fiscal second-quarter financial results. The company...

Wednesday, January 12, 2022, 04:37:00 PM

Great Bear: Canaccord Model Is Based On “Initial Applied Resource Of 4 Million Gold Ounces”

Yesterday, Great Bear Resources (TSXV: GBR) reported results from its ongoing exploration program at their...

Thursday, December 10, 2020, 11:21:00 AM

Columbia Care: Canaccord Reiterates $15 Price Target Following Q4 Results

On March 16th, Columbia Care (NEO: CCHW) reported their fourth quarter and year end financials...

Friday, March 19, 2021, 11:47:00 AM

BMO Reiterates Lundin Gold Following Production Beat

Lundin Gold (TSX: LUG) announced their second-quarter production results last week. The company announced that...

Monday, July 19, 2021, 04:22:00 PM

Antibe: Canaccord Cuts Price Target From $5.00 To $1.20 After Drug Pivot

In early August, Antibe Therapeutics Inc. (TSX: ATE) announced that they have paused their study...

Monday, October 18, 2021, 11:31:00 AM